Health
Phase 3 clinical trials for investigational COVID-19 vaccine underway – Mirage News
Baylor College of Medicine’s Vaccine and Treatment Evaluation Unit is one of approximately 90 sites selected to participate in the Phase 3 clinical trial…
Baylor College of Medicine’s Vaccine and Treatment Evaluation Unit is one of approximately 90 sites selected to participate in the Phase 3 clinical trial for Moderna’s investigational mRNA-1273 vaccine to evaluate the efficacy of the vaccine at preventing COVID-19 disease. Dr. Hana El Sahly, associate professor of molecular virology and microbiology and medicine at Baylor, serves as a national co-principal investigator of the trial.
Baylor’s Vaccine and Treatment Evaluation Unit is part of the …
Continue Reading